共 50 条
[32]
Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours
[J].
European Journal of Nuclear Medicine and Molecular Imaging,
2020, 47
:907-921
[34]
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
[J].
European Journal of Nuclear Medicine and Molecular Imaging,
2009, 36
[36]
Osseous metastases of gastro-enteropancreatic neuroendocrine tumours Diagnostic value of intra-therapeutic 177Lu-octreotate imaging in comparison with bone scintigraphy
[J].
NUKLEARMEDIZIN-NUCLEAR MEDICINE,
2012, 51 (03)
:95-100
[37]
Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours
[J].
European Journal of Nuclear Medicine and Molecular Imaging,
2008, 35
:743-748
[39]
Effect of peptide dose on radiation dosimetry for peptide receptor radionuclide therapy with 177Lu-DOTATOC: A pilot study
[J].
INDIAN JOURNAL OF NUCLEAR MEDICINE,
2021, 36 (04)
:412-421